(Q36671119)
Statements
A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma (English)
A R Clamp
P Vasey
M Soukop
R Coleman
G Halbert
L Robson
Cancer Research UK Phase I/II Committee
1 October 2003
1 reference
1 reference
1 reference